Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort.

PubWeight™: 2.80‹?› | Rank: Top 1%

🔗 View Article (PMID 20889909)

Published in Am J Respir Crit Care Med on October 01, 2010

Authors

Nicola A Hanania1, Hana Müllerova, Nicholas W Locantore, Jørgen Vestbo, Michael L Watkins, Emiel F M Wouters, Stephen I Rennard, Amir Sharafkhaneh, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study investigators

Author Affiliations

1: Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX 77030, USA. hanania@bcm.edu

Associated clinical trials:

Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints (ECLIPSE) | NCT00292552

Articles citing this

Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 1.72

Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med (2013) 1.62

Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis (2014) 1.23

Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int J Chron Obstruct Pulmon Dis (2014) 1.11

The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS One (2013) 1.03

Circadian clock function is disrupted by environmental tobacco/cigarette smoke, leading to lung inflammation and injury via a SIRT1-BMAL1 pathway. FASEB J (2013) 1.02

Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2014) 1.02

Chronic obstructive pulmonary disease. Indian J Med Res (2013) 1.02

Contribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypes. Med Clin North Am (2012) 0.98

Factors Associated with Depression in COPD: A Multicenter Study. Lung (2016) 0.96

Depression and anxiety in patients with COPD. Eur Respir Rev (2014) 0.95

Underrecognized comorbidities of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.95

Anxiety and depression-Important psychological comorbidities of COPD. J Thorac Dis (2014) 0.89

A score to predict short-term risk of COPD exacerbations (SCOPEX). Int J Chron Obstruct Pulmon Dis (2015) 0.88

Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study. Respir Res (2012) 0.88

Serotonin and corticosterone rhythms in mice exposed to cigarette smoke and in patients with COPD: implication for COPD-associated neuropathogenesis. PLoS One (2014) 0.86

Temperament and character profiles of male COPD patients. J Thorac Dis (2013) 0.86

Gender differences in symptoms and care delivery for chronic obstructive pulmonary disease. J Womens Health (Larchmt) (2012) 0.85

Comorbidity and sex-related differences in mortality in oxygen-dependent chronic obstructive pulmonary disease. PLoS One (2012) 0.85

Chronic obstructive pulmonary disease assessment test can predict depression: a prospective multi-center study. J Korean Med Sci (2013) 0.84

Presence of depression & its risk factors in patients with chronic obstructive pulmonary disease. Indian J Med Res (2014) 0.84

Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective. Br J Clin Pharmacol (2014) 0.84

Major affective disorders in chronic obstructive pulmonary disease compared with other chronic respiratory diseases. Int J Chron Obstruct Pulmon Dis (2015) 0.83

Suicidal ideation and suicide attempts in chronic obstructive pulmonary disease: the Korea National Health and Nutrition Examination Survey (KNHANES IV, V) from 2007-2012. NPJ Prim Care Respir Med (2014) 0.81

Depression in pulmonary arterial hypertension and interstitial lung diseases. N Am J Med Sci (2014) 0.81

Depressiveness, symptoms of anxiety and cognitive dysfunctions in patients with asthma and chronic obstructive pulmonary disease (COPD): possible associations with inflammation markers: a pilot study. J Neural Transm (Vienna) (2014) 0.81

Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis. Int J Chron Obstruct Pulmon Dis (2014) 0.80

Association of depression with disease severity in patients with chronic obstructive pulmonary disease. Lung (2014) 0.80

Strategies to improve anxiety and depression in patients with COPD: a mental health perspective. Neuropsychiatr Dis Treat (2016) 0.78

Predictors of depression in chronic obstructive pulmonary disease patients. Expert Rev Respir Med (2011) 0.78

Age-Related Differences in Health-Related Quality of Life in COPD: An Analysis of the COPDGene and SPIROMICS Cohorts. Chest (2015) 0.77

Depression in chronic obstructive pulmonary disease: a common concomitant disease. Am J Respir Crit Care Med (2011) 0.77

Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc (2016) 0.77

The Role of Mitochondria and Oxidative/Antioxidative Imbalance in Pathobiology of Chronic Obstructive Pulmonary Disease. Oxid Med Cell Longev (2016) 0.76

Forecasting COPD hospitalization in the clinic: optimizing the chronic respiratory questionnaire. Int J Chron Obstruct Pulmon Dis (2015) 0.76

A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 μg on health-related quality of life in patients with COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.75

Depression in individuals with chronic obstructive pulmonary disease and their informal caregivers. Aging Ment Health (2016) 0.75

Electronic health records and improved nursing management of chronic obstructive pulmonary disease. Patient Prefer Adherence (2015) 0.75

Disease knowledge level is a noteworthy risk factor of anxiety and depression in patients with chronic obstructive pulmonary disease: a cross-sectional study. BMC Pulm Med (2014) 0.75

Symptom profiles and inflammatory markers in moderate to severe COPD. BMC Pulm Med (2016) 0.75

The Effect of Fatigue and Fatigue Intensity on Exercise Tolerance in Moderate COPD. Lung (2016) 0.75

Improving communication between the physician and the COPD patient: an evaluation of the utility of the COPD Assessment Test in primary care. Patient Relat Outcome Meas (2014) 0.75

What else should we know about experiencing COPD? A narrative review in search of patients' psychological burden alleviation. Int J Chron Obstruct Pulmon Dis (2016) 0.75

Biobehavioral Prognostic Factors in Chronic Obstructive Pulmonary Disease: Results From the INSPIRE-II Trial. Psychosom Med (2016) 0.75

Managing multimorbidity in primary care in patients with chronic respiratory conditions. NPJ Prim Care Respir Med (2016) 0.75

The association of depressive symptoms and pulmonary function in healthy adults. Psychosom Med (2013) 0.75

Home telemonitoring for patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial. BMC Pulm Med (2016) 0.75

Screening tools for evaluation of depression in Chronic Obstructive Pulmonary Disease (COPD). A systematic review. Eur Clin Respir J (2017) 0.75

The effects of depression, anxiety and sleep disturbances on cognitive impairment in patients with chronic obstructive pulmonary disease. Cogn Neurodyn (2017) 0.75

Frequent Exacerbator: The Phenotype at Risk of Depressive Symptoms in Geriatric COPD Patients. Lung (2016) 0.75

Associations between the psychological health of patients and carers in advanced COPD. Int J Chron Obstruct Pulmon Dis (2017) 0.75

Articles by these authors

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med (2007) 19.86

Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med (2010) 15.07

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2003) 10.97

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA (2006) 10.54

A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet (2009) 6.93

Withdrawal of inhaled glucocorticoids and exacerbations of COPD. N Engl J Med (2014) 6.29

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med (2008) 6.17

Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med (2011) 5.69

Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity (2007) 5.36

Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res (2010) 5.17

An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med (2013) 4.49

Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med (2010) 4.19

Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. N Engl J Med (2015) 4.16

A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med (2012) 4.10

Budesonide and the risk of pneumonia: a meta-analysis of individual patient data. Lancet (2009) 3.93

Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 3.70

C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 3.69

Systemic effects of smoking. Chest (2007) 3.63

Risk indexes for exacerbations and hospitalizations due to COPD. Chest (2007) 3.55

Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 3.54

Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med (2012) 3.44

What is chronic obstructive pulmonary disease anyway?: Continua, categories, cut points, and moving beyond spirometry. Am J Respir Crit Care Med (2013) 3.39

Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med (2012) 3.00

Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest (2003) 2.90

FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts. Eur Respir J (2013) 2.87

Reversible cigarette smoke extract-induced DNA damage in human lung fibroblasts. Am J Respir Cell Mol Biol (2004) 2.82

Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA (2013) 2.59

'Highlights from this issue’ in the November issue of Thorax. Thorax (2013) 2.59

Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One (2012) 2.52

Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci U S A (2006) 2.51

Disturbed intestinal integrity in patients with COPD: effects of activities of daily living. Chest (2014) 2.27

Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome. Hum Mol Genet (2012) 2.24

Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 2.21

Differences in content and organisational aspects of pulmonary rehabilitation programmes. Eur Respir J (2013) 2.20

Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. Chest (2009) 2.20

Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation. Proc Natl Acad Sci U S A (2004) 2.19

Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19,732 men and women from The Copenhagen Centre for Prospective Population Studies. Am J Epidemiol (2002) 2.16

Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 2.13

Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD. Chest (2004) 2.08

A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD (2012) 2.07

Exercise capacity before and after an 8-week multidisciplinary inpatient rehabilitation program in lung cancer patients: a pilot study. Lung Cancer (2006) 2.07

Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation. Eur Respir J (2013) 2.05

Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med (2007) 2.04

Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 1.99

A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet (2011) 1.98

Inaccuracy of estimating peak work rate from six-minute walk distance in patients with COPD. COPD (2012) 1.98

Effects of neuromuscular electrical stimulation of muscles of ambulation in patients with chronic heart failure or COPD: a systematic review of the English-language literature. Chest (2009) 1.81

Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 1.79

Current controversies and future perspectives in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 1.79

A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo. Chest (2007) 1.79

Increased granzyme A expression in type II pneumocytes of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 1.76

Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine Tob Res (2006) 1.75

Cells derived from the circulation contribute to the repair of lung injury. Am J Respir Crit Care Med (2004) 1.74

Airway mucus: From production to secretion. Am J Respir Cell Mol Biol (2006) 1.73

Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease. Thorax (2012) 1.72

Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 1.72

Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. Ann Am Thorac Soc (2015) 1.72

Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology. Am J Respir Cell Mol Biol (2002) 1.71

Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med (2009) 1.70

Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med (2005) 1.67

Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial. Drugs (2008) 1.67

Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. Eur Respir J (2013) 1.66

Chronic obstructive pulmonary disease biomarker(s) for disease activity needed--urgently. Am J Respir Crit Care Med (2010) 1.66

Predictors of objective cough frequency in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 1.64

An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63

[Prevalence of chronic obstructive pulmonary disease in Copenhagen. Results from The Copenhagen City Heart Study]. Ugeskr Laeger (2007) 1.62

Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics (2006) 1.61

Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition (2003) 1.60

Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias. Am J Respir Crit Care Med (2005) 1.60

COPD: the dangerous underestimate of 15%. Lancet (2006) 1.60

Efficacy of tiotropium inhalation powder in african-american patients with chronic obstructive pulmonary disease. COPD (2008) 1.59

Risk factors for osteoporosis in Caucasian patients with moderate chronic obstructive pulmonary disease: a case control study. Bone (2012) 1.56

Proposal for a multidimensional staging system for chronic obstructive pulmonary disease. Respir Med (2005) 1.54

Leptin as regulator of pulmonary immune responses: involvement in respiratory diseases. Pulm Pharmacol Ther (2013) 1.54

Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. FASEB J (2004) 1.53

Pathogenesis of COPD. Semin Respir Crit Care Med (2005) 1.53

Chronic bronchitis in an elderly population. Age Ageing (2003) 1.51

Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am J Respir Crit Care Med (2008) 1.50

Critical view on diagnosing muscle wasting by single-frequency bio-electrical impedance in COPD. Respir Med (2009) 1.49

The role of leptin in the development of pulmonary neutrophilia in infection and acute lung injury. Crit Care Med (2014) 1.49

[Chronic obstructive pulmonary disease. Admission, course and prognosis]. Ugeskr Laeger (2003) 1.49

Overweight and obesity may lead to under-diagnosis of airflow limitation: findings from the Copenhagen City Heart Study. COPD (2014) 1.43

Tolerability and efficacy of inhaled AZD4818, a CCR1 antagonist, in moderate to severe COPD patients. Respir Med (2010) 1.41

The last wish of a patient with end stage chronic obstructive pulmonary disease. BMJ (2008) 1.41

Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med (2013) 1.41